Elizabeth Tu, DO | |
1400 S Coulter St Ste 5100, Amarillo, TX 79106-1786 | |
(806) 414-9559 | |
(806) 351-3767 |
Full Name | Elizabeth Tu |
---|---|
Gender | Female |
Speciality | Family Practice |
Experience | 8 Years |
Location | 1400 S Coulter St Ste 5100, Amarillo, Texas |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023463379 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | R9007 (Texas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Medical Center Of Mckinney | Mckinney, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Questcare Medical Clinics Pllc | 6608010541 | 24 |
News Archive
Research from Rutgers Cancer Institute of New Jersey examining difficult to treat cancer tumors through genomic profiling shows that tumors with alterations in a signaling pathway responsible for cell regulation may respond to targeted therapy regardless of where the tumor originated in the body.
Parkinson's UK is launching a new funding program to support innovative studies into non-drug treatments for Parkinson's.
Dr. Marc McKee, of McGill's Faculty of Dentistry and the Department of Anatomy and Cell Biology, is collaborating closely with Enobia Pharma Inc, a Quebec biotech company, to develop innovative treatments for serious genetic bone diseases. McKee's research looks into the reasons why calcium-phosphate mineral fails to crystallize properly to form strong bones and teeth.
Velocity Technology Solutions, Inc. a leader in cloud-based enterprise software hosting, application management, and consulting services, announced today that it was selected by the St. Charles Health System, Inc. to host and fully-manage its Lawson enterprise resource planning applications and Kronos time and labor management applications. Velocity's expertise and demonstrated leadership in supporting the Lawson and Kronos applications, as well as its partnership with both software providers, were driving forces behind St. Charles' decision.
ProtAffin AG, a biotechnology company developing a novel class of biopharmaceutical products that act by targeting cell-surface glycan structures, today presents compelling preclinical data in chronic obstructive pulmonary disease (COPD) for its lead product PA401 at the European Respiratory Society Congress in Barcelona, Spain. This conference is the largest gathering of scientists and clinicians in the respiratory community in the world. The Oral Presentation will be made in the session "Pre-clinical models of airways disease".
› Verified 2 days ago
Entity Name | Concord Medical Group Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1083630610 PECOS PAC ID: 0446296818 Enrollment ID: O20050707000531 |
News Archive
Research from Rutgers Cancer Institute of New Jersey examining difficult to treat cancer tumors through genomic profiling shows that tumors with alterations in a signaling pathway responsible for cell regulation may respond to targeted therapy regardless of where the tumor originated in the body.
Parkinson's UK is launching a new funding program to support innovative studies into non-drug treatments for Parkinson's.
Dr. Marc McKee, of McGill's Faculty of Dentistry and the Department of Anatomy and Cell Biology, is collaborating closely with Enobia Pharma Inc, a Quebec biotech company, to develop innovative treatments for serious genetic bone diseases. McKee's research looks into the reasons why calcium-phosphate mineral fails to crystallize properly to form strong bones and teeth.
Velocity Technology Solutions, Inc. a leader in cloud-based enterprise software hosting, application management, and consulting services, announced today that it was selected by the St. Charles Health System, Inc. to host and fully-manage its Lawson enterprise resource planning applications and Kronos time and labor management applications. Velocity's expertise and demonstrated leadership in supporting the Lawson and Kronos applications, as well as its partnership with both software providers, were driving forces behind St. Charles' decision.
ProtAffin AG, a biotechnology company developing a novel class of biopharmaceutical products that act by targeting cell-surface glycan structures, today presents compelling preclinical data in chronic obstructive pulmonary disease (COPD) for its lead product PA401 at the European Respiratory Society Congress in Barcelona, Spain. This conference is the largest gathering of scientists and clinicians in the respiratory community in the world. The Oral Presentation will be made in the session "Pre-clinical models of airways disease".
› Verified 2 days ago
Entity Name | Questcare Hospitalists Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1265441620 PECOS PAC ID: 5799785119 Enrollment ID: O20070109000581 |
News Archive
Research from Rutgers Cancer Institute of New Jersey examining difficult to treat cancer tumors through genomic profiling shows that tumors with alterations in a signaling pathway responsible for cell regulation may respond to targeted therapy regardless of where the tumor originated in the body.
Parkinson's UK is launching a new funding program to support innovative studies into non-drug treatments for Parkinson's.
Dr. Marc McKee, of McGill's Faculty of Dentistry and the Department of Anatomy and Cell Biology, is collaborating closely with Enobia Pharma Inc, a Quebec biotech company, to develop innovative treatments for serious genetic bone diseases. McKee's research looks into the reasons why calcium-phosphate mineral fails to crystallize properly to form strong bones and teeth.
Velocity Technology Solutions, Inc. a leader in cloud-based enterprise software hosting, application management, and consulting services, announced today that it was selected by the St. Charles Health System, Inc. to host and fully-manage its Lawson enterprise resource planning applications and Kronos time and labor management applications. Velocity's expertise and demonstrated leadership in supporting the Lawson and Kronos applications, as well as its partnership with both software providers, were driving forces behind St. Charles' decision.
ProtAffin AG, a biotechnology company developing a novel class of biopharmaceutical products that act by targeting cell-surface glycan structures, today presents compelling preclinical data in chronic obstructive pulmonary disease (COPD) for its lead product PA401 at the European Respiratory Society Congress in Barcelona, Spain. This conference is the largest gathering of scientists and clinicians in the respiratory community in the world. The Oral Presentation will be made in the session "Pre-clinical models of airways disease".
› Verified 2 days ago
Entity Name | Questcare Medical Clinics Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1821430166 PECOS PAC ID: 6608010541 Enrollment ID: O20130916000718 |
News Archive
Research from Rutgers Cancer Institute of New Jersey examining difficult to treat cancer tumors through genomic profiling shows that tumors with alterations in a signaling pathway responsible for cell regulation may respond to targeted therapy regardless of where the tumor originated in the body.
Parkinson's UK is launching a new funding program to support innovative studies into non-drug treatments for Parkinson's.
Dr. Marc McKee, of McGill's Faculty of Dentistry and the Department of Anatomy and Cell Biology, is collaborating closely with Enobia Pharma Inc, a Quebec biotech company, to develop innovative treatments for serious genetic bone diseases. McKee's research looks into the reasons why calcium-phosphate mineral fails to crystallize properly to form strong bones and teeth.
Velocity Technology Solutions, Inc. a leader in cloud-based enterprise software hosting, application management, and consulting services, announced today that it was selected by the St. Charles Health System, Inc. to host and fully-manage its Lawson enterprise resource planning applications and Kronos time and labor management applications. Velocity's expertise and demonstrated leadership in supporting the Lawson and Kronos applications, as well as its partnership with both software providers, were driving forces behind St. Charles' decision.
ProtAffin AG, a biotechnology company developing a novel class of biopharmaceutical products that act by targeting cell-surface glycan structures, today presents compelling preclinical data in chronic obstructive pulmonary disease (COPD) for its lead product PA401 at the European Respiratory Society Congress in Barcelona, Spain. This conference is the largest gathering of scientists and clinicians in the respiratory community in the world. The Oral Presentation will be made in the session "Pre-clinical models of airways disease".
› Verified 2 days ago
Entity Name | Concord Medical Group Of Texas Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1750790762 PECOS PAC ID: 7810117223 Enrollment ID: O20141007002567 |
News Archive
Research from Rutgers Cancer Institute of New Jersey examining difficult to treat cancer tumors through genomic profiling shows that tumors with alterations in a signaling pathway responsible for cell regulation may respond to targeted therapy regardless of where the tumor originated in the body.
Parkinson's UK is launching a new funding program to support innovative studies into non-drug treatments for Parkinson's.
Dr. Marc McKee, of McGill's Faculty of Dentistry and the Department of Anatomy and Cell Biology, is collaborating closely with Enobia Pharma Inc, a Quebec biotech company, to develop innovative treatments for serious genetic bone diseases. McKee's research looks into the reasons why calcium-phosphate mineral fails to crystallize properly to form strong bones and teeth.
Velocity Technology Solutions, Inc. a leader in cloud-based enterprise software hosting, application management, and consulting services, announced today that it was selected by the St. Charles Health System, Inc. to host and fully-manage its Lawson enterprise resource planning applications and Kronos time and labor management applications. Velocity's expertise and demonstrated leadership in supporting the Lawson and Kronos applications, as well as its partnership with both software providers, were driving forces behind St. Charles' decision.
ProtAffin AG, a biotechnology company developing a novel class of biopharmaceutical products that act by targeting cell-surface glycan structures, today presents compelling preclinical data in chronic obstructive pulmonary disease (COPD) for its lead product PA401 at the European Respiratory Society Congress in Barcelona, Spain. This conference is the largest gathering of scientists and clinicians in the respiratory community in the world. The Oral Presentation will be made in the session "Pre-clinical models of airways disease".
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Elizabeth Tu, DO 4510 Bell St, Amarillo, TX 79109-5714 Ph: (469) 855-6080 | Elizabeth Tu, DO 1400 S Coulter St Ste 5100, Amarillo, TX 79106-1786 Ph: (806) 414-9559 |
News Archive
Research from Rutgers Cancer Institute of New Jersey examining difficult to treat cancer tumors through genomic profiling shows that tumors with alterations in a signaling pathway responsible for cell regulation may respond to targeted therapy regardless of where the tumor originated in the body.
Parkinson's UK is launching a new funding program to support innovative studies into non-drug treatments for Parkinson's.
Dr. Marc McKee, of McGill's Faculty of Dentistry and the Department of Anatomy and Cell Biology, is collaborating closely with Enobia Pharma Inc, a Quebec biotech company, to develop innovative treatments for serious genetic bone diseases. McKee's research looks into the reasons why calcium-phosphate mineral fails to crystallize properly to form strong bones and teeth.
Velocity Technology Solutions, Inc. a leader in cloud-based enterprise software hosting, application management, and consulting services, announced today that it was selected by the St. Charles Health System, Inc. to host and fully-manage its Lawson enterprise resource planning applications and Kronos time and labor management applications. Velocity's expertise and demonstrated leadership in supporting the Lawson and Kronos applications, as well as its partnership with both software providers, were driving forces behind St. Charles' decision.
ProtAffin AG, a biotechnology company developing a novel class of biopharmaceutical products that act by targeting cell-surface glycan structures, today presents compelling preclinical data in chronic obstructive pulmonary disease (COPD) for its lead product PA401 at the European Respiratory Society Congress in Barcelona, Spain. This conference is the largest gathering of scientists and clinicians in the respiratory community in the world. The Oral Presentation will be made in the session "Pre-clinical models of airways disease".
› Verified 2 days ago
Dr. David Thetford, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 275 Casino Dr, Amarillo, TX 79118 Phone: 806-884-9943 | |
Brian Gillette, MHS, PA-C Family Medicine Medicare: Medicare Enrolled Practice Location: 1100 S Coulter St, Amarillo, TX 79106 Phone: 806-468-9700 | |
Pamela K Banister, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3501 S Soncy Rd Ste 150, Amarillo, TX 79119 Phone: 806-212-6353 Fax: 806-212-0558 | |
Dr. Wesley Scott Nickens, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2701 S Georgia St, Amarillo, TX 79109 Phone: 806-350-8980 Fax: 806-350-7573 | |
Genkai Jason Huang, Family Medicine Medicare: Medicare Enrolled Practice Location: 2701 S Georgia St, Amarillo, TX 79109 Phone: 806-350-8980 Fax: 806-350-7573 | |
Gary J Hilton, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2701 S Georgia St, Amarillo, TX 79109 Phone: 806-350-3000 Fax: 806-350-3337 |